GRGuangcong Ruan

Guangcong Ruan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guangcong Ruan has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Xuefei Zhao

    Chongqing Key Laboratory of Digestive Malignancies, Department of Gastroenterology, Engineering Research Center for Advanced Medical Technology in Microecological Therapy of Chongqing, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China

    2 shared publications
  • Ailin Yi

    Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University (Third Military Medical University), China

    1 shared publication
  • Ailin Yi

    Chongqing Key Laboratory of Digestive Malignancies, Department of Gastroenterology, Engineering Research Center for Advanced Medical Technology in Microecological Therapy of Chongqing, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China

    1 shared publication
  • Guoyan Zheng

    Shanghai Jiao Tong University, Shanghai, China

    1 shared publication
  • Huan Yang

    Chongqing Key Laboratory of Digestive Malignancies, Department of Gastroenterology, Engineering Research Center for Advanced Medical Technology in Microecological Therapy of Chongqing, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China

    1 shared publication
  • Kechen Lin

    Department of Gastroenterology, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China

    1 shared publication

Latest Publications

  • Open Access

    Age-Related Alterations in Human Gut Microbiota and Intestinal Aging: Microbial Signatures, Disease Associations and Intervention Strategies

    by Siyu Li, Minjia Chen, Huan Yang, Xuefei Zhao, Yuting Tian, Yi Cheng, Qiwei Wu, Yangyang Feng, Lu Chen, Ailin Yi, et al.

    Aging is accompanied by progressive alterations in gut homeostasis, characterized by gut microbiota dysbiosis, impaired intestinal barrier function, immune dysregulation, and chronic low-grade inflammation. Increasing evidence indicates that age-related gut microbial remodeling is closely associated with the development of multiple age-associated disorders, including frailty, sarcopenia, cardiovascular diseases, and neurodegenerative diseases. However, existing reviews have primarily focused on individual aspects of gut microbiota-mediated aging, whereas a systematic framework integrating gut microbial dysbiosis, intestinal aging, and the development of multiple age-related diseases through shared pathogenic mechanisms remains lacking. This review provides a comprehensive synthesis of age-related alterations in human gut microbiota, with particular emphasis on bacterial taxa consistently associated with healthy aging and age-related diseases. We further integrate current evidence to examine the associations between age-related microbial alterations and intestinal aging, with particular attention to microbial function, barrier integrity, and host immune responses. Finally, we review microbiota-targeted interventions, including fecal microbiota transplantation, probiotics, prebiotics, and dietary modulation, and discuss their potential and limitations in promoting healthy aging. By integrating mechanistic evidence with findings from human observational cohorts and clinical intervention studies, this review provides a translational framework for understanding microbiota-mediated intestinal aging and highlights future directions for precision microbiota-based strategies to promote healthy aging.

  • Open Access

    Subclass-Aware Contrastive Semi-Supervised Learning for Inflammatory Bowel Disease Classification from Colonoscopy Images

    by Kechen Lin, Guangcong Ruan, Xiaoyang Zou, Yongjian Nian, Yanling Wei, Guoyan Zheng

    Inflammatory bowel disease (IBD) includes Crohn’s disease (CD) and ulcerative colitis (UC). The accurate classification of IBD from colonoscopy images is critical for diagnosis and treatment. However, the lack of labeled data poses a major challenge for developing deep learning-based IBD classification approaches. Recently, pseudo-labeling-based semi-supervised learning methods offer a promising solution in leveraging both labeled and unlabeled data to improve classification performance. Nevertheless, due to significant intra-class variability and the subtle inter-class differences in IBD colonoscopy images, pseudo-labels are often inaccurate, which results in confirmation bias and suboptimal performance. To address this challenge, a Subclass-Aware Contrastive Semi-Supervised Learning method, referred to as SACSSL, is proposed for accurate IBD classification by integrating a subclass-aware contrastive module into a pseudo-labeling-based semi-supervised framework, e.g., FixMatch. Specifically, unlabeled samples are first partitioned into confident and uncertain samples according to the confidence of pseudo-labels. An instance-level contrastive loss is then applied to uncertain samples, aiming to mitigate confirmation bias. Furthermore, intra-class heterogeneity is captured by introducing a set of prototypes for each subclass and assigning confident samples to these prototypes to form fine-grained subclasses, and supervised contrastive loss is applied to promote intra-subclass clustering, thereby enhancing inter-class separability while preserving intra-class diversity. Our method is evaluated on two datasets, i.e., an in-house collected Daping dataset for IBD classification and a publicly available LIMUC dataset for UC severity grading. On both datasets, our method achieves state-of-the-art performance under the semi-supervised setting. Specifically, with only 20% labeled data, the proposed method reaches an overall accuracy of 93.2% and an F1-score of 80.1% on the Daping dataset, which is close to the fully supervised upper bound (94.0% accuracy and 80.8% F1-score), and it achieves an overall accuracy of 76.4% and an F1-score of 68.9% on the LIMUC dataset. Comprehensive experimental results demonstrate the effectiveness of our method for semi-supervised colonoscopy image classification.


  • Open Access

    Multi-omics assessment of gut microbiota in circadian rhythm disorders: a cross-sectional clinical study

    by Yuting Tian, Rong Zhao, Shili Xiao, Lu Chen, Yi Cheng, Wei Meng, Zongyuan Tang, Yi Cai, Zhifeng Xiao, Ailin Yi, et al.

    Background: The interaction between the host and microbiota is influenced by host circadian rhythm. However, it is unknown what the changes of gut microbiota and metabolites.Methods: We conducted a cross-sectional study (n=72) in which participants’ fecal DNA was detected by macrogenomic sequencing analysis. The feces, urine and blood were analyzed by widely targeted metabolomics analysis.Results: Pearson correlation analysis showed that most of the clinical symptoms of people with circadian rhythm disorders were moderately positively correlated with gastrointestinal symptoms. By distilling the results of multinomic analysis, we reported a variety of different species (19 species in the gut) and metabolites. In our results, the correlation of multiomics is mostly concentrated in Lachnospiraceae bacterium and Streptococcus mitis oralis pneumoniae. Bile acid-related metabolites are the most significant metabolites associated with these species.Discussion: Our study demonstrates the severity of clinical manifestations caused by circadian rhythm disorder is closely related to microbiota and metabolism. In the future, personalized interventions targeting specific microbial species or metabolites may help alleviate the physical and psychological discomfort induced by circadian rhythm disturbances.